首页> 美国卫生研究院文献>Springer Open Choice >Transcutaneous oxygen pressure as a predictor for short-term survival in patients with type 2 diabetes and foot ulcers: a comparison with ankle–brachial index and toe blood pressure
【2h】

Transcutaneous oxygen pressure as a predictor for short-term survival in patients with type 2 diabetes and foot ulcers: a comparison with ankle–brachial index and toe blood pressure

机译:经皮氧压可作为2型糖尿病和足溃疡患者短期生存的预测指标:与踝肱指数和脚趾血压的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimsAnkle–brachial index (ABI) is the most commonly used test when diagnosing peripheral vascular disease and is considered a marker for cardiovascular risk. Transcutaneous oxygen pressure (TcPO2), a test associated with microvascular function, has in several studies shown better correlation with diabetic foot ulcer (DFU) healing. Whether a low TcPO2 could be a marker for mortality in the high-risk population of DFU patients has not been evaluated before. The aim of this study was to evaluate the predictive value of TcPO2 in comparison with ABI and toe blood pressure (TBP) on 1-year mortality in type 2 diabetes patients with DFU.
机译:Aims踝臂指数(ABI)是诊断周围血管疾病时最常用的测试,被认为是心血管风险的标志。经皮的氧压(TcPO2)是一项与微血管功能相关的测试,在多项研究中显示出与糖尿病足溃疡(DFU)愈合的相关性更好。以前尚未评估过低TcPO2是否可以作为DFU高危人群死亡率的标志。这项研究的目的是评估TcPO2与ABI和脚趾血压(TBP)对2型DFU糖尿病患者1年死亡率的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号